Ralf Huss

About

Application of Artificial Intelligence, Big Data and Nanotechnology in Biomedicine; Biomarker Discovery and Development applying Computational Pathology; Proven Executive Leadership in Pharmaceutical, Biotech & Diagnostics • Extensive Academic Track Record in Anatomical / Digital Pathology, Oncology, Immunology, Stem Cell Research & Precision Medicine • Research & Development Leadership • Product Development form Drug Research to Market • Business Development • Operational Excellence • Change Management

Experience

• Chief Medical Officer at Definiens, The Tissue Phenomics Company
  Aug 2015 - Present · 11 yrs

  Strategic and executive guidance of tissue-based assay development (anatomical / digital pathology) and responsible for medical affairs; integration of artificial intelligence

• Co Founder & CSO at apceth GmbH & Co. KG
  Oct 2011 - Jun 2015 · 3 yrs 9 mos

  R&D of cellular biopharmaceuticals and gene products, Pharmaceutical & technical development including scale up and down Streaming - Leader of Biomarker discovery

• Roche Diagnostics (6 yrs 3 mos)
  • VP and Global Head Therapeutic Cell Intiative
    May 2008 - Sep 2011 · 3 yrs 5 mos

    Evaluation and implementation of (stem) cell-based R&D and cellular therapeutics as a therapeutic modality and Business unit

  • Head of Pathology and Tissue Biomarker
    Jul 2005 - May 2008 · 2 yrs 11 mos

    Discovery and implementation of tissue-based biomarker including assay development

• Assistant Professor Pathology at Ludwig-Maximilians Universität München
  May 1995 - Jul 2005 · 10 yrs 3 mos

• Senior Clinical Consultant at University Hospital Essen
  Oct 1994 - Apr 1995 · 7 mos